financetom
Technology
financetom
/
Technology
/
Applied Materials may postpone or cancel $4 billion California R&D facility, SF Chronicle reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Applied Materials may postpone or cancel $4 billion California R&D facility, SF Chronicle reports
Apr 8, 2024 4:16 PM

(Reuters) - Applied Materials ( AMAT ), the largest maker of semiconductor equipment in the U.S., may postpone or abandon its plans to build a $4 billion research and development facility in Silicon Valley due to a lack of government funding, the San Francisco Chronicle reported on Monday citing sources familiar with the matter.

The Biden administration said last month it would scrap plans to fund the program from the $52.7 billion Chips and Science Act due to "overwhelming demand" for funding awards to subsidize chip production.

Applied Materials ( AMAT ) did not immediately respond to a Reuters request for comment.

President Joe Biden had signed the bill in August 2022 amid a global shortage of chips, in a bid to bolster U.S. competitiveness with China in science and technology.

The measure aimed to subsidize U.S. chip manufacturing and expand research funding to address a recurrent shortfall that had harmed a variety of sectors, from cars and weaponry to washing machines and video games.

Applied Materials ( AMAT ), a strong candidate for a research award from the program, announced its plans for the California research center in May 2023 to speed up advances in semiconductor manufacturing.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exploring The Competitive Space: Taiwan Semiconductor Versus Industry Peers In Semiconductors & Semiconductor Equipment
Exploring The Competitive Space: Taiwan Semiconductor Versus Industry Peers In Semiconductors & Semiconductor Equipment
Oct 14, 2024
In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Taiwan Semiconductor and its primary competitors in the Semiconductors & Semiconductor Equipment industry. By closely examining key financial metrics, market position, and growth prospects, our aim is to provide valuable...
Performance Comparison: Microsoft And Competitors In Software Industry
Performance Comparison: Microsoft And Competitors In Software Industry
Oct 14, 2024
In today's rapidly changing and highly competitive business world, it is imperative for investors and industry observers to carefully assess companies before making investment choices. In this article, we will undertake a comprehensive industry comparison, evaluating Microsoft ( MSFT ) vis-à-vis its key competitors in the Software industry. Through a detailed analysis of important financial indicators, market standing, and growth...
Deep Dive Into Jamf Holding Stock: Analyst Perspectives (7 Ratings)
Deep Dive Into Jamf Holding Stock: Analyst Perspectives (7 Ratings)
Oct 14, 2024
In the last three months, 7 analysts have published ratings on Jamf Holding ( JAMF ) , offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish...
Catalent to sell New Jersey facility
Catalent to sell New Jersey facility
Oct 14, 2024
(Reuters) - Catalent ( CTLT ) has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on Monday. Catalent ( CTLT ) provides contract manufacturing services and performs fill-finish work, which involves the sterile filling and packaging of syringes and injection pens, for drugmakers including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved